CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.494
https://www.valueinhealthjournal.com/article/S1098-3015(12)02207-3/fulltext
Title :
CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02207-3&doi=10.1016/j.jval.2012.08.494
First page :
A281
Section Title :
Cardiovascular Disease Outcomes Research
Open access? :
No
Section Order :
21